Invesco
PTLA

Invesco’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Invesco’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-294,877
Closed -$2.1M – 3723
2020
Q1 		$2.1M Sell
294,877
-2,323
-0.8% -$29K ﹤0.01% 2368
2019
Q4 		$7.1M Sell
297,200
-209,197
-41% -$5.77M ﹤0.01% 1949
2019
Q3 		$13.6M Buy
506,397
+303,955
+150% +$8.53M ﹤0.01% 1595
2019
Q2 		$5.49M Sell
202,442
-788
-0.4% -$24.7K ﹤0.01% 2119
2019
Q1 		$7.05M Buy
203,230
+10,905
+6% +$315K ﹤0.01% 1772
2018
Q4 		$3.75M Buy
192,325
+352
+0.2% +$7.24K ﹤0.01% 2107
2018
Q3 		$5.11M Buy
191,973
+813
+0.4% +$26.5K ﹤0.01% 2127
2018
Q2 		$7.22M Buy
191,160
+35,221
+23% +$1.35M ﹤0.01% 1901
2018
Q1 		$5.09M Buy
155,939
+15,291
+11% +$671K ﹤0.01% 1946
2017
Q4 		$6.85M Sell
140,648
-8,857
-6% -$448K ﹤0.01% 1791
2017
Q3 		$8.08M Buy
149,505
+4,439
+3% +$261K ﹤0.01% 1691
2017
Q2 		$8.15M Buy
145,066
+78,726
+119% +$3.15M ﹤0.01% 1672
2017
Q1 		$2.6M Buy
+66,340
New +$2.11M ﹤0.01% 2403
2016
Q4 		– Sell
-172,240
Closed -$3.91M – 3729
2016
Q3 		$3.91M Buy
172,240
+24,842
+17% +$583K ﹤0.01% 2138
2016
Q2 		$3.48M Buy
147,398
+45,771
+45% +$1.13M ﹤0.01% 2151
2016
Q1 		$2.07M Sell
101,627
-98,404
-49% -$3.12M ﹤0.01% 2447
2015
Q4 		$10.3M Buy
200,031
+5,189
+3% +$252K ﹤0.01% 1475
2015
Q3 		$8.3M Buy
194,842
+90,055
+86% +$4.35M ﹤0.01% 1539
2015
Q2 		$4.77M Buy
104,787
+564
+0.5% +$22.7K ﹤0.01% 2026
2015
Q1 		$3.96M Buy
104,223
+58,468
+128% +$2.01M ﹤0.01% 2140
2014
Q4 		$1.3M Buy
+45,755
New +$1.27M ﹤0.01% 2790

Other funds holding PTLA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Invesco's PTLA Position: Q2 2020 in Review

Invesco sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 294,877 shares — an estimated $2.1M sold.

Invesco first reported a position in PTLA in Q4 2014 and held it in 21 quarters. The position peaked at $13.6M in Q3 2019. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

  • Invesco reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Invesco sold 294,877 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $2.1M.
  • Invesco first reported a position in Portola Pharmaceuticals, Inc. in Q4 2014 and held it in 21 quarters.
  • Invesco's Portola Pharmaceuticals, Inc. position peaked at $13.6M in Q3 2019.
  • 162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on Invesco's 13F filing for Q2 2020, filed 14 Aug 2020.